First Manhattan’s Medifast MED Stock Holding History

First Manhattan’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-700	Closed	-$26.8K	–	1056
2024 Q1	$26.8K	Hold	700	–	–	﹤0.01%	986
2023 Q4	$47.1K	Hold	700	–	–	﹤0.01%	885
2023 Q3	$52.4K	Hold	700	–	–	﹤0.01%	860
2023 Q2	$64.5K	Hold	700	–	–	﹤0.01%	841
2023 Q1	$72.6K	Hold	700	–	–	﹤0.01%	856
2022 Q4	$80.7K	Hold	700	–	–	﹤0.01%	862
2022 Q3	$75K	Hold	700	–	–	﹤0.01%	871
2022 Q2	$126K	Hold	700	–	–	﹤0.01%	797
2022 Q1	$119K	Hold	700	–	–	﹤0.01%	848
2021 Q4	$146K	Hold	700	–	–	﹤0.01%	807
2021 Q3	$134K	Hold	700	–	–	﹤0.01%	816
2021 Q2	$198K	Hold	700	–	–	﹤0.01%	737
2021 Q1	$148K	Hold	700	–	–	﹤0.01%	763
2020 Q4	$137K	Hold	700	–	–	﹤0.01%	736
2020 Q3	$115K	Hold	700	–	–	﹤0.01%	756
2020 Q2	$97K	Hold	700	–	–	﹤0.01%	773
2020 Q1	$43K	Hold	700	–	–	﹤0.01%	875
2019 Q4	$76K	Hold	700	–	–	﹤0.01%	837
2019 Q3	$72K	Hold	700	–	–	﹤0.01%	847
2019 Q2	$89K	Hold	700	–	–	﹤0.01%	841
2019 Q1	$89K	Hold	700	–	–	﹤0.01%	851
2018 Q4	$87K	Hold	700	–	–	﹤0.01%	821
2018 Q3	$155K	Hold	700	–	–	﹤0.01%	767
2018 Q2	$112K	Hold	700	–	–	﹤0.01%	800
2018 Q1	$65K	Hold	700	–	–	﹤0.01%	899
2017 Q4	$48K	Hold	700	–	–	﹤0.01%	1010
2017 Q3	$41K	Hold	700	–	–	﹤0.01%	995
2017 Q2	$29K	Hold	700	–	–	﹤0.01%	1031
2017 Q1	$31K	Hold	700	–	–	﹤0.01%	1034
2016 Q4	$29K	Hold	700	–	–	﹤0.01%	1010
2016 Q3	$26K	Hold	700	–	–	﹤0.01%	1039
2016 Q2	$23K	Hold	700	–	–	﹤0.01%	1082
2016 Q1	$21K	Buy	+700	New	+$20.5K	﹤0.01%	1059

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

First Manhattan's MED Position: Q2 2024 in Review

First Manhattan sold out of Medifast (MED) in Q2 2024, closing a stake of 700 shares — an estimated $26.8K sold.

First Manhattan first reported a position in MED in Q1 2016 and held it in 33 quarters. The position peaked at $198K in Q2 2021. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

First Manhattan reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 700 Medifast shares in Q2 2024, an estimated $26.8K.
First Manhattan first reported a position in Medifast in Q1 2016 and held it in 33 quarters.
First Manhattan's Medifast position peaked at $198K in Q2 2021.
158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.